Allogeneic hematopoietic stem. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy45

Hematopoietic Stem Cells Stem Cells Allografts Bone Marrow Cells T-Lymphocytes Fetal Blood Cells, Cultured Bone Marrow Adult Stem Cells Neoplastic Stem Cells Plant Stems Antilymphocyte Serum Thymus Gland Hematopoietic System Multipotent Stem Cells Mesonephros CD8-Positive T-Lymphocytes Pluripotent Stem Cells CD4-Positive T-Lymphocytes Dendritic Cells B-Lymphocytes Killer Cells, Natural Spleen Mesenchymal Stromal Cells T-Lymphocytes, Regulatory Fetal Stem Cells Myeloid Progenitor Cells Induced Pluripotent Stem Cells T-Lymphocytes, Cytotoxic Blood Cells Neural Stem Cells T-Lymphocyte Subsets Lymphocytes Stromal Cells Myeloid Cells Clone Cells Lymphoid Progenitor Cells Granulocytes Yolk Sac Cell Line Embryo, Mammalian Fetus Gonads Brain Stem Megakaryocytes

Organisms18

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, Inbred BALB C Radiation Chimera Mice, SCID Mice, Inbred NOD BK Virus Lentivirus Mice, Knockout Mice, Transgenic Retroviridae Mice, Inbred Strains Chimera Mice, Congenic Mice, Inbred C3H Mice, Mutant Strains Mice, Inbred DBA

Diseases37

Graft vs Host Disease Hematologic Neoplasms Leukemia Recurrence Hematologic Diseases Myelodysplastic Syndromes Leukemia, Myeloid, Acute Cytomegalovirus Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Acute Disease Cystitis Hepatic Veno-Occlusive Disease Leukemic Infiltration Anemia, Aplastic Opportunistic Infections Neoplasm, Residual Lymphoproliferative Disorders Severe Combined Immunodeficiency Mycoses Bronchiolitis Obliterans Leukemia, Myeloid Primary Myelofibrosis Blood Group Incompatibility Chronic Disease Multiple Myeloma Leukemia-Lymphoma, Adult T-Cell Aspergillosis Sarcoma, Myeloid Leukemia, Lymphocytic, Chronic, B-Cell Epstein-Barr Virus Infections Neoplasms, Second Primary Neoplasms Disease Progression Bacteremia Neoplasm Recurrence, Local Myeloproliferative Disorders

Chemicals and Drugs44

Myeloablative Agonists Busulfan Vidarabine Antigens, CD34 HLA Antigens Immunosuppressive Agents Isoantigens Minor Histocompatibility Antigens Antilymphocyte Serum Cyclophosphamide Stem Cell Factor Ganciclovir Granulocyte Colony-Stimulating Factor Antigens, CD Antibodies, Neoplasm HLA-A Antigens Cyclosporine Pyrimidines Antibodies, Monoclonal Proto-Oncogene Proteins c-kit Antifungal Agents Antineoplastic Agents Biological Markers Cytarabine Cytokines Triazoles Antiviral Agents Antigens, Ly Interferon-gamma Antigens, CD38 Amphotericin B Chemokine CXCL12 Antigens, Thy-1 Antigens, CD45 Thrombopoietin Antigens, Viral Interleukin Receptor Common gamma Subunit GATA2 Transcription Factor Green Fluorescent Proteins DNA, Viral Core Binding Factor Alpha 2 Subunit Receptors, CXCR4 Hematopoietic Cell Growth Factors Antigens, Differentiation

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Bone Marrow Transplantation Stem Cell Transplantation Whole-Body Irradiation Treatment Outcome Histocompatibility Testing Retrospective Studies Peripheral Blood Stem Cell Transplantation Transplantation, Autologous Hematopoietic Stem Cell Mobilization Flow Cytometry Cord Blood Stem Cell Transplantation Lymphocyte Transfusion Transplantation, Isogeneic Remission Induction Survival Rate Lymphocyte Depletion Survival Analysis Colony-Forming Units Assay Follow-Up Studies Combined Modality Therapy Photopheresis Cell Separation Salvage Therapy Risk Factors Immunosuppression Disease-Free Survival Immunophenotyping Fatal Outcome Lymphocyte Activation Prognosis Immunotherapy, Adoptive Lymphocyte Culture Test, Mixed Incidence Prospective Studies Transduction, Genetic Immunotherapy Antineoplastic Combined Chemotherapy Protocols Multivariate Analysis Polymerase Chain Reaction Chemoprevention Coculture Techniques Lymphocyte Count Skin Transplantation Mesenchymal Stem Cell Transplantation Cohort Studies Genetic Therapy Kaplan-Meier Estimate Clinical Trials as Topic Cell Count Transplantation, Heterologous Reverse Transcriptase Polymerase Chain Reaction Risk Cell Transplantation Cell Culture Techniques Leukocyte Transfusion Viral Load Blood Cell Count Leukapheresis Blood Transfusion, Autologous Gene Transfer Techniques Graft Enhancement, Immunologic Case-Control Studies Models, Biological Gene Expression Profiling

Psychiatry and Psychology1

Phenomena and Processes43

Graft vs Leukemia Effect Graft vs Tumor Effect Histocompatibility Chimerism Hematopoiesis Graft Survival Time Factors Cell Lineage Transplantation Immunology Stem Cell Niche Cell Differentiation Immunocompromised Host Cell Proliferation Radiation Chimera Graft Rejection Virus Activation Lymphocyte Activation Transduction, Genetic Lymphopoiesis Hematopoiesis, Extramedullary Genetic Vectors Lymphocyte Count Cell Division Graft vs Host Reaction Phenotype Cytotoxicity, Immunologic Cell Count Myelopoiesis Signal Transduction Risk Cell Movement Cell Survival Transplantation Tolerance Immune Tolerance Viral Load Recovery of Function Blood Cell Count Regeneration Cell Cycle Gene Expression Regulation Genotype Gene Expression Cellular Microenvironment

Anthropology, Education, Sociology and Social Phenomena1

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups6

Tissue Donors Siblings Survivors Living Donors Infant, Newborn Unrelated Donors

Health Care16

Treatment Outcome Retrospective Studies Survival Rate Survival Analysis Follow-Up Studies Risk Factors Disease-Free Survival Fatal Outcome Incidence Prospective Studies Multivariate Analysis Cohort Studies Kaplan-Meier Estimate Clinical Trials as Topic Risk Case-Control Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Hematopoietic Stem Cells Graft vs Host Disease Transplantation Conditioning Hematologic Neoplasms Graft vs Leukemia Effect Stem Cells Transplantation Chimera Bone Marrow Transplantation Tissue Donors Stem Cell Transplantation Graft vs Tumor Effect Myeloablative Agonists Leukemia Histocompatibility Whole-Body Irradiation Allografts Chimerism Busulfan Treatment Outcome Hematopoiesis Graft Survival Vidarabine Recurrence Histocompatibility Testing Hematologic Diseases Retrospective Studies Peripheral Blood Stem Cell Transplantation Myelodysplastic Syndromes Leukemia, Myeloid, Acute Transplantation, Autologous Bone Marrow Cells Hematopoietic Stem Cell Mobilization Mice, Inbred C57BL T-Lymphocytes Cytomegalovirus Infections Flow Cytometry Antigens, CD34 Siblings Cord Blood Stem Cell Transplantation HLA Antigens Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphocyte Transfusion Leukemia, Myelogenous, Chronic, BCR-ABL Positive Transplantation, Isogeneic Immunosuppressive Agents Acute Disease Cystitis Time Factors Cell Lineage Remission Induction Hepatic Veno-Occlusive Disease Isoantigens Fetal Blood Transplantation Immunology Minor Histocompatibility Antigens Survival Rate Leukemic Infiltration Anemia, Aplastic Lymphocyte Depletion Survival Analysis Opportunistic Infections Stem Cell Niche Colony-Forming Units Assay Cell Differentiation Cytomegalovirus Cells, Cultured Bone Marrow Neoplasm, Residual Adult Stem Cells Lymphoproliferative Disorders Severe Combined Immunodeficiency Mycoses Follow-Up Studies Combined Modality Therapy Neoplastic Stem Cells Photopheresis Bronchiolitis Obliterans Plant Stems Leukemia, Myeloid Primary Myelofibrosis Cell Separation Antilymphocyte Serum Cyclophosphamide Immunocompromised Host Salvage Therapy Thymus Gland Risk Factors Immunosuppression Disease-Free Survival Immunophenotyping Mice, Inbred BALB C Stem Cell Factor Ganciclovir Blood Group Incompatibility Hematopoietic System Cell Proliferation Multipotent Stem Cells Radiation Chimera

No FAQ available that match "allogeneic hematopoietic stem"